Dr. Leann Michelle Blankenship, MD

Dr. Blankenship practices at Epic Care in Emeryville, California.

Dr. Blankenship's NPI, 1659634772, was assigned on June 22, 2012. Dr. Blankenship graduated from St. George's University School of Medicine in 2012. Dr. Blankenship's Michigan license number on file is 4301107781.

Dr. Blankenship's primary practice is Epic Care, at 1480 64th St, Emeryville, CA 94608 in Alameda County. The practice phone is (925) 778-0679.

Dr. Blankenship's primary practice is Epic Care in Emeryville, California. Dr. Blankenship is also affiliated with Stanford Hospital at 300 Pasteur Drive. The medical group on file is Epic Care. Dmand AI also links Dr. Blankenship to 4 more hospitals, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Blankenship practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Blankenship's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Blankenship is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Blankenship's licenses on file in 2 states: Michigan and California.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer and lymphoma among the conditions Dr. Blankenship treats.

CMS data shows 39,198 Medicare services from Dr. Blankenship across 47 procedure codes in 2024, for 717 Medicare patients. Medicare paid $685,639 for them.

CMS counts 717 Medicare patients who saw Dr. Blankenship in 2024. The largest group is 65 to 74, with 306 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 36% are also on Medicaid. Their average risk score is 2.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Blankenship's median patient age at 69, with 73% women.

In 2024, Dr. Blankenship wrote 1,808 Medicare Part D claims for 336 patients. 81% of them were for generic drugs. CMS names the drug for 1,349 of them, across 37 drugs with 11 or more claims each, at $2,045,645 in total drug cost. In 2023, CMS named 1,182 claims across 34 drugs.

Dr. Blankenship accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Blankenship as offering telehealth.

Dmand AI links 2 papers to Dr. Blankenship, published from 2017 to 2021. Dr. Blankenship's most frequent co-authors are Nwabundo Ifeyinwa Anusim, MD, Daniel Emeka Ezekwudo, MD and Bolanle Mariam Gbadamosi, MD.

CMS Open Payments shows 858 general payments to Dr. Blankenship from 82 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 80% of the total. Agios Pharmaceuticals, Inc. paid the most, $4,240.

Dr. Blankenship graduated from St. George's University School of Medicine in 2012.

Dr. Blankenship is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.